Excerpts

Thus, the elimination rate in females was almost 50%, while males showed almost no elimination; this difference was highly significant (Wilcoxon-Mann-Whitney-Test, P = 0.0084).

In fact, between 8–30 weeks, the curve of the body-weight kinetics of aP2-ALOX15 mice was consistently below the curve of the wildtype controls, and this difference was statistically highly significant (Wilcoxon test, p < 0.0085).

ITS analysis indicated that ADENO positivity, which had been decreasing by 0.56% per year prepandemic (95% CI, 0.40%–0.72%; P < .0001), reversed to an increasing trend of +1.0% per year postemergence (95% CI, 0.28%–1.7%; P = .0085; for trend change, P = .0003; Figure 3 , Supplementary Table 4 ).

The percentage of non-PC cases ranged from 11.0% in 2010 to 18.0% in 2015 ( Fig 2 B), with a significant trend for increasing proportion over time ( P = .0085).

18 Although the cohort of East Asian meta‐analysis showed a nominally significant protective effect of His13 in HLA‐DRβ1 ( P = 0.0086), its association was not observed in the Japanese cohort ( P = 0.69).

The difference in overall survival by site of bone involvement among patients ≤40 is highly significant (p=0.0086).

The second one were patients with chronic OSD in regard to change in the Lysholm scale, which showed a possible trend for significant association between given parameters ( p = 0.0086).

ADIPOQ SNP rs12495941 was significantly associated after adjusting for age, PEA, biological risk factors and behavioral risk factors, but the association attenuated and became marginally non-significant after adjusting for SES (model 6: ß (SE) = 0.40 (0.15), p =0.0086).

The survival rates of the different groups of rats were different as the median survival for the group of rats which had received huBcl-2 A15A5 and pCMV A15A5 cells were respectively 10.2 and 15.6 days, a difference, which was highly significant ( P = 0.0086) (figure 3A ).

We find provisioning has a small, borderline-significant effect ( P = 0.045, effect = −27.5%) on the age at weaning, but our results indicate that a more-important driver of earlier age at weaning may be infant carrying, especially by males (although this model is not quite significant either: P = 0.0086, effect = −48.9%; male carrying is the model with the lowest AIC, and the AIC of “others carrying” is within 2).

The associations in MC4R (combined MAF = 0.79%, minimum P = 2.7 × 10 −10 , odds ratio = 2.07, 95% confidence interval = 1.65–2.59) and PAM (combined MAF = 4.9%, weighted P = 2.2 × 10 − 9 , odds ratio = 1.44, 95% confidence interval = 1.28–1.62) result largely from effects of the previously identified coding variants in these genes, although the MC4R signal remained nominally significant after removing Ile269Asn ( P = 8.6 × 10 −3 ; Supplementary Fig. 7 ) and the PAM signal remained nominally significant ( P < 0.05) after removing the 35 strongest individually associated PAM variants (Supplementary Fig. 8 ).

In men, however, the overall differences did achieve statistical significance ( P < .0001) with Asian Indians specifically having a significantly higher median value compared to Chinese ( P = .0001) and a higher median compared to NHW that was not quite statistically significant ( P = .0086).

Wilcoxon testing (after 52 weeks of trial) further indicated a highly significant sex difference in the placebo groups (** P = 0.00867, Table S1 ), with the GDS score improving significantly in davunetide-treated females, as compared to the placebo group, at week 52 (* P = 0.0178, Fig. 3C and Table S1 ).

aeruginosa showed an increasing trend in urine specimens (β = 0.92296; 95% CI: 0.00278–0.01042; p = 0.00868), while S. aureus exhibited a decline in mucocutaneous swabs (β = −0.82685; 95% CI: −0.00963 to −0.00028; p = 0.04238).

As the supplementary distributional measure, the proportion of population with UIC < 100 μg/L has shown an increasing trend (β = 0.018, P < 0.0087) from 37.6% (95%CI 30.0, 46.0) in 2001–2002 to 47.7% (95%CI 41.9, 54.0) in 2017–2020.

Comparison of median sMet levels in subjects with no cytologic atypia to those with any degree of atypia (atypia, suspicious for cancer or positive for cancer) showed a trend towards statistical significance (p = 0.0087) but did not meet the significance threshold adjustment for 14 correlative tests (p < 0.0036); these results were further limited as only 48/183 (26.2%) of subjects had cytologic analysis performed.

FLT3LG was produced by purified CD4+ T cells (p=0.0623) and by DCs (p=0.1193) 24 hours following stimulation with cGAMP, and this induction became highly significant (p=0.0087) when data from the two cell subsets were combined, as distinct biological replicates, into one analysis ( Fig. 6e ).

The CV-ANOVA revealed that the model was highly significant ( p = 0.008781).

In the B6JJcl group, lactating females showed a lower percentage of sucrose preference than nulliparous and nonlactating females, although the differences failed to reach significance after Bonferroni correction ( p = 0.0088 and p = 0.0228, respectively).

Additionally, stress exposure and food access interacted to influence L-DOPA concentrations [ F (1,31) = 4.22, p = 0.0485], however, post hoc analyses failed to reach significance. 3.2.4 Cecal contents Stressed rats had elevated levels of 5-HIAA/5-HT [ F (1,31) = 7.83, p = 0.0088], which was likely a result of increased 5-HIAA concentration [ F (1,31) = 4.70, p = 0.0380] compared to unstressed rats ( Figure 4A ).

Also, a highly significant ( p = 0.0088) correlation of volume of solution spread and solution spread in the parapharyngeal space and “medial compartment” was found.

66) is highly significant ( P = 0.0088, χ 2 test).

In particular, the height from the dental arch of the leakage or perforation was identified as a highly significant risk factor ( P = 0.0088).

Four SNPs near QKI showed nominally significant association with MI (p-value<8.8×10 −3 ) and three exceeded the genome-wide significance threshold when Stage I and Stage II results were combined (top SNP rs6941513: p = 6.2×10 −9 ).

Nine women out of 17 in the vagitocin 400 IU group did not experience the most bothersome symptom after seven weeks of treatment; the corresponding figures were 14 and 13 in the placebo group. The difference in the decrease of the number of women experiencing the most bothersome symptom between the start of treatment and after the seven-week treatment period was highly significant when the results in the vagitocin 400 IU and placebo groups were compared ( p = 0.0089).